Subscribe to RSS
DOI: 10.1055/s-0040-1715586
COVID-19 Infection and Its Influence in Otorhinolaryngology-Head and Neck Surgery
Abstract
Introduction The novel coronavirus disease 2019 pandemic has rapidly spread worldwide, challenging healthcare resources and communities to an unprecedent degree. Simultaneously, the amount of clinical and scientific information released has overwhelmed journal platforms.
Objectives This review aims to summarize the available diagnostic tools and current guidelines to safely assist patients while limiting the exposure of otolaryngologists during this pandemic.
Data Synthesis Key articles were retrieved from the following databases: PubMed, Lancet, Springer Nature, BioMed Central, JAMA network and MEDLINE, as well as updated documents from the Spanish Ministry of Health, World Health Organization, Centers for Disease Control and Prevention, Spanish Association of Surgeons, ENT-UK, American College of Surgeons, and American Academy of Otolaryngology-Head and Neck Surgery. The terms used for the search were: COVID-19, Test COVID, Surgery in COVID, 2019-nCoV, ‘coronavirus’, and SARS-CoV-2. A total of 10,245 papers were retrieved. The inclusion criteria for the review included: COVID-19 testing (n = 531), society guidelines for otolaryngology-head and neck surgery patient care in the outpatient clinic (n = 10) and surgical (n = 18) settings. Studies not related to COVID-19 diagnosis were excluded.
Conclusion Healthcare institutions around the world are outlining their own protocols regarding laboratory testing and personnel protective equipment usage based upon medical societies recommendations during the COVID-19 pandemic. We have summarized the available laboratory tests and their respective sensitivity and specificity. Moreover, clinical guidelines from different societies were reviewed and summarized to facilitate guidance for otolaryngologists in the operating room and in the clinical settings.
Publication History
Received: 29 June 2020
Accepted: 05 July 2020
Article published online:
24 September 2020
© 2020. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Thieme Revinter Publicações Ltda
Rio de Janeiro, Brazil
-
References
- 1 Madhav N, Oppenheim B, Gallivan M, Mulembakani P, Rubin E, Wolfe N. Pandemics: Risks, Impacts, and Mitigation. In: rd Jamison DT, Gelband H, Horton S, Jha P, Laxminarayan R. et al. Disease Control Priorities: Improving Health and Reducing Poverty. Washington (DC): 2017
- 2 Xu K, Lai X, Liu Z. Suggestions on the prevention of COVID-19 for health care workers in department of otorhinolaryngology head and neck surgery. World J Otorhinolaryngol Head Neck Surg 2020
- 3 National Institute of Health. COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. 2020 [Available from: https://www.covid19treatmentguidelines.nih.gov/
- 4 Guan WJ, Ni ZY, Hu Y. , et al; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020; 382 (18) 1708-1720
- 5 van Doremalen N, Bushmaker T, Morris DH. et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med 2020; 382 (16) 1564-1567
- 6 Rothe C, Schunk M, Sothmann P. et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N Engl J Med 2020; 382 (10) 970-971
- 7 World Health Organization. Coronavirus disease (COVID-19) advice for the public. 2020 [Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public
- 8 Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: A review. Clin Immunol 2020; 215: 108427
- 9 Lauer SA, Grantz KH, Bi Q. et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med 2020; 172 (09) 577-582
- 10 Brann DH, Tsukahara T, Weinreb C. et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia: BioRxiv; 2020 [updated 05/18/. 2020 . Available from: https://www.biorxiv.org/content/10.1101/2020.03.25.009084v4.full
- 11 Oudkerk M, Büller HR, Kuijpers D. et al. Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands. Radiology 2020; 201629
- 12 World Health Organization. Report of the WHO-Joint Mission on Coronavirus Disease 2019 (COVID-19). 2020 [Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019
- 13 World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). 2020 [Available from: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf
- 14 Giannis D, Ziogas IA, Gianni P. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. J Clin Virol 2020; 127: 104362
- 15 Huang C, Wang Y, Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395 (10223): 497-506
- 16 Pascarella G, Strumia A, Piliego C. et al. COVID-19 diagnosis and management: a comprehensive review. J Intern Med 2020
- 17 Wang W, Xu Y, Gao R. et al. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA 2020
- 18 de Sociedad E. Enfermedades Infecciosas y Microbiología Clínica. Recomendaciones Institucionales: Documento de Posicionamiento de la SEIMC sobre el diagnóstico microbiólogo de COVID-19. [Institutional recommendations. SEIMC positioning on the microbiological diagnosis of COVID-19.]. 2020 [Available from: https://seimc.org/contenidos/documentoscientificos/recomendaciones/seimc-rc-2020-Posicionamiento_SEIMC_diagnostico_microbiologico_COVID19.pdf
- 19 Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Recomendaciones de SEIMC sobre el uso de las pruebas de detección de anticuerpos. [SEIMC Recommendations on the use of Antibody Detection Testing.]. 2020 [Available from: https://seimc.org/contenidos/documentoscientificos/recomendaciones/seimc-rc-2020-Recomendaciones_uso_de_las_pruebas_de_deteccion_de_anticuerpos.pdf
- 20 Guo L, Ren L, Yang S. et al. Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19). Clin Infect Dis 2020; ciaa310
- 21 Zainol Rashid Z, Othman SN, Abdul Samat MN, Ali UK, Wong KK. Diagnostic performance of COVID-19 serology assays. Malays J Pathol 2020; 42 (01) 13-21
- 22 Carter LJ, Garner LV, Smoot JW. et al. Assay Techniques and Test Development for COVID-19 Diagnosis. ACS Cent Sci 2020; 6 (05) 591-605
- 23 Jacofsky D, Jacofsky EM, Jacofsky M. Understanding Antibody Testing for COVID-19. J Arthroplasty 2020; S0883–5403 (Suppl. 20) 30442-30443
- 24 Jennings K. FDA Authorizes First-Ever Crispr Application For COVID-19 Coronavirus Test: Forbes;. 2020 [Available from: https://www.forbes.com/sites/katiejennings/2020/05/07/fda-authorizes-first-ever-crispr-application-for-covid-19-coronavirus-test/#2bdd017a1708
- 25 Chappell B. WHO Says COVID-19 Immunity Is An Unknown; Disease '10 Times Deadlier' Than 2009 Flu: NPR. 2020 [Available from: https://www.npr.org/sections/coronavirus-live-updates/2020/04/13/833534116/who-says-covid-19-immunity-is-an-unknown-disease-10-times-deadlier-than-2009-flu
- 26 Centers for Disease Control and Prevention (CDC). Coronavirus Disease 2019: Infection Control Guidance. 2020 [Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control-recommendations.html
- 27 Couloigner V, Schmerber S, Nicollas R. , et al; French Society of Otorhinolaryngology, Head, Neck Surgery (SFORL); French College of Otorhinolaryngology, Head, Neck Surgery; French Syndicate of ENT Specialists (SNORL). COVID-19 and ENT Surgery. Eur Ann Otorhinolaryngol Head Neck Dis 2020; 137 (03) 161-166
- 28 Ministerio de Sanidad de España. Enfermedad por coronavirus, COVID-19 [Coronavirus disease, COVID-19]. 2020 [Available from: https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/ITCoronavirus.pdf
- 29 Setzen G, Anne S, Brown III EG. et al. Guidance for Return to Practice for Otolaryngology-Head and Neck Surgery: Part One: American Academy of Otolaryngology-Head and Neck Surgery. 2020 [Available from: https://www.entnet.org/sites/default/files/uploads/guidance_for_return_to_practice_part_one_final_050520.pdf
- 30 Givi B, Schiff BA, Chinn SB. et al. Safety Recommendations for Evaluation and Surgery of the Head and Neck During the COVID-19 Pandemic. JAMA Otolaryngol Head Neck Surg 2020
- 31 American Academy of Otolaryngology-Head and Neck Surgery. Tracheotomy Recommendations During the COVID-19 Pandemic. 2020 [Available from: https://www.entnet.org/content/tracheotomy-recommendations-during-covid-19-pandemic
- 32 Boccalatte LA, Larrañaga JJ, Perez Raffo GM. et al. Brief guideline for the prevention of COVID-19 infection in head and neck and otolaryngology surgeons. Am J Otolaryngol 2020; 41 (03) 102484
- 33 Howard BE. High-Risk Aerosol-Generating Procedures in COVID-19: Respiratory Protective Equipment Considerations. Otolaryngol Head Neck Surg 2020; 163 (01) 98-103
- 34 Patel ZM, Fernandez-Miranda J, Hwang PH. et al. Letter: Precautions for Endoscopic Transnasal Skull Base Surgery During the COVID-19 Pandemic. Neurosurgery 2020; 87 (01) E66-E67
- 35 Public Health England. COVID-19: infection prevention and control guidance. 2020 [Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/886668/COVID-19_Infection_prevention_and_control_guidance_complete.pdf
- 36 Public Health Scotland. Assessing the evidence base for medical procedures which create a higher risk of respiratory infection transmission from patient to healthcare worker: Public Health Scotland. 2020 [Available from: https://hpspubsrepo.blob.core.windows.net/hps-website/nss/3055/documents/1_agp-sbar.pdf
- 37 Tran K, Cimon K, Severn M, Pessoa-Silva CL, Conly J. Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review. PLoS One 2012; 7 (04) e35797
- 38 Vukkadala N, Qian ZJ, Holsinger FC, Patel ZM, Rosenthal E. COVID-19 and the Otolaryngologist: Preliminary Evidence-Based Review. Laryngoscope 2020
- 39 Al-Muharraqi MA. Testing recommendation for COVID-19 (SARS-CoV-2) in patients planned for surgery - continuing the service and ‘suppressing’ the pandemic. Br J Oral Maxillofac Surg 2020; S0266–4356 (20) 30164-30169
- 40 Abbott. Abbott Launches COVID-19 Antibody Test. 2020 [Available from: https://www.abbott.com/corpnewsroom/product-and-innovation/abbott-launches-covid-19-antibody-test.html
- 41 Roche. Roche's COVID-19 antibody test receives FDA Emergency Use Authorization and is available in markets accepting the CE mark. 2020 [Available from: https://diagnostics.roche.com/global/en/news-listing/2020/roches-covid-19-antibody-test-receives-fda-emergency-use-authorization.html
- 42 Bio-Rad Laboratories Inc. Bio-Rad's SARS-CoV-2 (COVID-19) Serology Test Granted FDA Emergency Use Authorization, the First Total Antibody Test to Receive EUA from the FDA. 2020 [Available from: https://www.bio-rad.com/en-us /corporate/newsroom/bio-rads-sars-cov-2-covid-19-serology-test-granted-fda-emergency-use-authorization-first-total-antibody-test-receive-eua-span-classforcebreaks-fda?ID=Bio-Rad-s-SARS-CoV-2_1588272430&tlp-link=[COVID-19%20qPCR%20Assay%20Development%20Solutions]%20[SARS-CoV-2%20EUA%20News]
- 43 DiaSorin. The fully automated serology test to detect IgG antibodies against SARS-CoV-2. 2020 [Available from: https://www.diasorin.com/en/immunodiagnostic-solutions/clinical-areas/infectious-diseases/covid-19
- 44 Cellex. Cellex qSARS-CoV-2 IgG/IgM Rapid Test. 2020 [Available from: https://www.fda.gov/media/136625/download
- 45 Lassaunière R, Frische A, Harboe ZB. et al. Evaluation of nine commercial SARS-CoV-2 immunoassays: medRxiv. 2020 [Available from: https://www.medrxiv.org/content/10.1101/2020.04.09.20056325v1.full.pdf
- 46 Ortho-Clinical Diagnostics Inc. VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Reagent Pack. 2020 [Available from: https://www.fda.gov/media/137363/download
- 47 Ortho-Clinical Diagnostics Inc. VITROS Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack. 2020 [Available from: https://www.fda.gov/media/136967/download
- 48 Junta de Castilla y León. SACYL. Indicaciones y procedimiento de utilización de test diagnósticos de infección COVID-19. [Indications and procedure for utilization of diagnostic tests for COVID-19 infection]. 2020 [Available from: https://www.saludcastillayleon.es/es/covid-19/informacion-profesionales/atencion-primaria/actuacion-atencion-primaria.ficheros/1599304-Guia%20breve%20para%20la%20utilizacio%C2%BFn%20de%20test%20diagno%C2%BFsticos%20en%20Infeccio%C2%BFn%20por%20COVID%20080520.pdf
- 49 Zheng S, Fan J, Yu F. et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. BMJ 2020; 369: m1443
- 50 Lall S. SHERLOCK-based one-step test provides rapid and sensitive Covid-19 detection: MIT News. 2020 [Available from: http://news.mit.edu/2020/sherlock-based-one-step-test-provides-rapid-sensitive-covid-19-detection-0505
- 51 Spanish Association of Surgery (AEC). General Recommendations of Urgent Surgical Care in the Context of The COVID-19 Pandemic (SARS CoV-2) From The Spanish Association Of Surgery (AEC). 2020 [Available from: https://www.aecirujanos.es/files/noticias/158/documentos/4_-_Recomendaciones_for_URGENT_Surgical_care_during_the_pandemic_COVID_19__v_2.pdf